Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29361583 | 1.00 | TSHR (0.47) | TSHRCYP2C9PDE4AALDH1A1TP53 | |
| SCHEMBL14038079 | 1.00 | TSHR (0.47) | TSHRCYP2C9PDE4AALDH1A1TP53 | |
| SCHEMBL29424095 | 1.00 | TSHR (0.47) | TSHRCYP2C9PDE4AALDH1A1TP53 | |
| SCHEMBL29623845 | 1.00 | TSHR (0.47) | TSHRCYP2C9PDE4AALDH1A1TP53 | |
| SCHEMBL11037568 | 1.00 | TSHR (0.47) | TSHRCYP2C9PDE4AALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL23929292 | 0.92 | PDE4A (0.46) | TSHRCYP2C9PDE4AALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL23929291 | 0.92 | PDE4A (0.46) | TSHRCYP2C9PDE4AALDH1A1TP53 | |
| Mucic Acid SCHEMBL23388836 | 0.92 | PDE4A (0.46) | TSHRCYP2C9PDE4AALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL5974 | 0.92 | PDE4A (0.46) | TSHRCYP2C9PDE4AALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL2559030 | 0.92 | PDE4A (0.46) | TSHRCYP2C9PDE4AALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028524-A1 | BLEND OF PHOSPHONATE ACIDS FOR SCALE PREVENTION IN HIGH ALKALINITY AND HIGH CO2 ENVIRONMENTS | HALLIBURTON ENERGY SERVICES, INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4661684-A1 | MONOPHASE GELS OF NON-POLAR LIQUIDS WITH NON-IONIC SURFACTANTS | Technikum Laubholz GmbH (DE) | 2025-12-17 | — | — | EP | claimed |
| US-20250369124-A1 | IMIDAZOLINE-SUGAR CONJUGATE COMPOSITIONS AND METHODS FOR INHIBITING CORROSION | ECOLAB USA INC. (US) | 2025-12-04 | — | — | US | claimed |
| US-20250369123-A1 | ALKOXYIMIDAZOLINIUM QUATERNARY SALT COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS TO INHIBIT CORROSION | ECOLAB USA INC. (US) | 2025-12-04 | — | — | US | claimed |
| EP-4581096-A1 | COMPOSITIONS AND METHODS FOR DISSOLVING IRON SULFIDE AND INHIBITING CORROSION | ECOLAB USA INC. (US) | 2025-07-09 | — | — | EP | claimed |
| US-12122745-B2 | Processes for preparing aldaric, aldonic, and uronic acids | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2024-10-22 | — | — | US | claimed |
| US-20240084459-A1 | COMPOSITIONS AND METHODS FOR DISSOLVING IRON SULFIDE AND INHIBITING CORROSION | ECOLAB USA INC. (US) | 2024-03-14 | — | — | US | claimed |
| WO-2024049583-A1 | COMPOSITIONS AND METHODS FOR DISSOLVING IRON SULFIDE AND INHIBITING CORROSION | ECOLAB USA INC. (US) | 2024-03-07 | — | — | WO | claimed |
| EP-4296403-A2 | COMPOSITION FOR REMEDIATING IRON SULFIDE IN OILFIELD PRODUCTION SYSTEMS | ChampionX USA Inc. (US) | 2023-12-27 | — | — | EP | claimed |
| EP-3548581-B1 | COMPOSITION FOR REMEDIATING IRON SULFIDE IN OILFIELD PRODUCTION SYSTEMS | CHAMPIONX USA INC (US) | 2023-09-06 | — | — | EP | claimed |
| CN-116359375-A | Plant polysaccharide glycosidic bond detection method and high-throughput automatic detection equipment thereof | 浙江大学 | 2023-06-30 | — | — | CN | claimed |
| US-20230183554-A1 | COMPOSITION FOR REMEDIATING IRON SULFIDE IN OILFIELD PRODUCTION SYSTEMS | CHAMPIONX LLC | 2023-06-15 | — | — | US | claimed |
| US-11597868-B2 | Composition for remediating iron sulfide in oilfield production systems | CHAMPIONX USA INC. (US) | 2023-03-07 | — | — | US | claimed |
| US-20230028813-A1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | ARCHER DANIELS MIDLAND CO (US) | 2023-01-26 | — | — | US | claimed |
| EP-4112594-A1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | Archer-Daniels-Midland Company (US) | 2023-01-04 | — | — | EP | claimed |
| EP-3822247-B1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | ARCHER DANIELS MIDLAND CO (US) | 2022-06-08 | — | — | EP | claimed |
| US-12618813-B2 | Method for detecting glycosidic bonds of plant polysaccharides | ZHEJIANG UNIVERSITY (CN) | 2026-05-05 | — | — | US | disclosed |
| US-12618813-B2 | Method for detecting glycosidic bonds of plant polysaccharides | ZHEJIANG UNIVERSITY (CN) | 2026-05-05 | — | — | US | disclosed |
| WO-2022118982-A1 | PROCESS FOR TREATING KERATIN FIBERS | L'OREAL (FR) | 2022-06-09 | — | — | WO | disclosed |
| EP-3822247-B1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | ARCHER DANIELS MIDLAND CO (US) | 2022-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618813-B2 | Method for detecting glycosidic bonds of plant polysaccharides | ALG1, PAG1, ACP1 | TSHR 4379/4885CYP2C9 2028/4885PDE4A 3055/4885 |
| US-20260028524-A1 | BLEND OF PHOSPHONATE ACIDS FOR SCALE PREVENTION IN HIGH ALKALINITY AND HIGH CO2 ENVIRONMENTS | PHOSPHO1, WEE1, PEBP1 | TSHR 4533/4885CYP2C9 3641/4885PDE4A 2939/4885 |
| US-20230028813-A1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | ALDOA, AKR1C4, ADSL | TSHR 4053/4885CYP2C9 583/4885PDE4A 3856/4885 |
| US-12122745-B2 | Processes for preparing aldaric, aldonic, and uronic acids | ALDOA, AKR1C4, ADSL | TSHR 4053/4885CYP2C9 583/4885PDE4A 3856/4885 |
| US-20250369124-A1 | IMIDAZOLINE-SUGAR CONJUGATE COMPOSITIONS AND METHODS FOR INHIBITING CORROSION | SI, FUT5, MGAM | TSHR 2258/4885CYP2C9 398/4885PDE4A 2799/4885 |
| US-20250369123-A1 | ALKOXYIMIDAZOLINIUM QUATERNARY SALT COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS TO INHIBIT CORROSION | TFPI, F12, TFPI2 | TSHR 4408/4885CYP2C9 570/4885PDE4A 4044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.